What Restandol (Testosterone) Treats: Main Uses and Benefits

Restandol (Testosterone undecanoate) is applied across domains where additional symptomatic support is needed in adult males diagnosed with symptomatic hypogonadism, a condition characterized by systemic imbalance. It is generally used to provide supportive relief when symptoms create noticeable physiological strain and interfere with daily functioning. Testosterone is used for managing low or no testosterone levels in men.

---

Therapeutic Benefit Domains

The medication is commonly used to help with groups of symptoms related to sexual function (like reduced libido and erectile dysfunction), physical decline (such as loss of muscle mass and strength), and neuropsychiatric manifestations (including persistent fatigue and depressed mood). This support assists with maintaining functional stability and contributes to improved comfort during symptomatic periods.

Restandol is relevant for managing symptom clusters that may become intense or disruptive. It supports the management of symptoms related to physical discomfort and managing the symptoms of organ-specific functional stress. Furthermore, in situations where patients experience mood changes or energy loss, it offers symptomatic relief that helps patients cope more steadily with symptom fluctuations, generally supporting overall well-being.

---

Quick Fact: Used for Symptoms of Physical Weakness and Fatigue

Regulatory References

1. Testosterone: MedlinePlus Drug Information

Who Can and Cannot Use Restandol (Testosterone)?

Eligibility for Restandol (testosterone undecanoate) is strictly governed by regulatory classifications detailing who is permitted to use the medicine, who is restricted, and who is absolutely prohibited.

---

Eligibility Scope

Category	Regulatory Statement
Approved Population	Adult males with clinically confirmed symptomatic hypogonadism (testosterone deficiency) due to established structural or genetic causes.
Absolute Contraindication	Men with known or suspected carcinoma of the prostate or carcinoma of the breast. The medicine is also strictly contraindicated for all women, especially those who are pregnant.
Use Not Established	Males less than 18 years old, as safety and efficacy have not been established. There is also limited experience in patients over 65 years of age.
Conditional Use Required	Patients with severe cardiac, hepatic, or renal insufficiency or uncontrolled hypertension require close monitoring. Treatment must be stopped immediately if severe complications like edema or congestive heart failure occur.

The medicine is not recommended for men whose low testosterone is due to conditions other than structural or genetic causes, such as certain forms of age-related hypogonadism.

Interactions with other medicines and products

Official regulatory documentation describes interaction patterns for Restandol (testosterone undecanoate) that primarily affect the exposure or pharmacodynamic action of co-administered medicines.

Documented Interaction Patterns

The following interaction statements reflect information found in government-approved prescribing labels:

• Oral Vitamin K Antagonist Anticoagulants (e.g., Warfarin): Co-administration may cause changes in anticoagulant activity and necessitates frequent monitoring of International Normalized Ratio (INR) and prothrombin time (PT).
• Insulin and other Antidiabetic Agents: Concurrent use may lead to a decrease in blood glucose, which may require a reduction in the dose of the antidiabetic medicine.
• Corticosteroids (or ACTH): Simultaneous use may enhance oedema formation (fluid retention), a risk that specifically requires careful monitoring in patients with underlying cardiac, renal, or hepatic disease.
• Enzyme-Inducing Agents (e.g., Barbiturates): These agents may lead to increased clearance of testosterone, potentially causing decreased testosterone levels.
• Medications that May Also Increase Blood Pressure: These substances may contribute to additive effects on blood pressure when taken together.
• Herbal Products: Certain herbal products, such as St. John's Wort, are noted to potentially interfere with steroid metabolism, which may decrease plasma testosterone levels.

No formal drug-drug combinations are explicitly classified as contraindicated in the interaction sections of the regulatory labels.

Restandol, which contains testosterone undecanoate, functions as a pro-drug. Following administration, non-specific endogenous esterases cleave the undecanoate ester bond, releasing the active steroid, testosterone, into the circulation. A proportion of this circulating testosterone is converted by the enzyme 5alpha-reductase into the more potent androgen, dihydrotestosterone (DHT), primarily in target tissues such as the prostate, hair follicles, and liver.

The biological targets for both testosterone and DHT are androgen receptors (ARs), which are intracellular ligand-activated transcription factors found in the cytoplasm and nucleus of cells in target tissues, including skeletal muscle, bone, skin, and the pituitary gland. Upon binding of the androgen (agonist interaction type) to the AR, the hormone-receptor complex translocates to the cell nucleus. The complex then binds to specific DNA sequences known as Androgen Response Elements (AREs) in the promoter regions of target genes. This binding event modulates (typically enhances or represses) gene transcription, leading to an alteration in mRNA and subsequent protein synthesis. At the system level, this cascade modulates the development and maintenance of secondary sexual characteristics, spermatogenesis, hematopoiesis, and body composition through changes in protein anabolism and bone matrix deposition. A second, non-genomic pathway involves rapid, AR-mediated signaling cascades at the cell membrane, which influences various intracellular signaling molecules. Furthermore, testosterone can undergo aromatization by the cytochrome P450 enzyme aromatase into estradiol, which then acts as an agonist on estrogen receptors ( ERs) to modulate processes in tissues like bone, the pituitary, and adipose tissue.

The administration of Restandol follows specific protocols for the appropriate route, timing, and dosage adjustments. This medication is administered via the oral route as a soft capsule containing testosterone undecanoate. The usage is critically dependent on timing with meals; the capsule must be taken with a normal meal to ensure proper absorption, and it should be swallowed whole with fluid.

The therapy follows a divided, twice-daily schedule, with the total daily dose split between a morning and an evening administration. If an uneven number of capsules is prescribed daily, the greater portion is taken with the morning meal.

Treatment commences with an initial dose, typically ranging from 120 mg to 160 mg daily, sustained for an introductory period of two to three weeks. The dosage is then titrated downward to a long-term maintenance dose, typically between 40 mg and 120 mg daily. This adjustment is based on the observed clinical effect and monitoring of serum testosterone concentrations. Initiation and overall management of this therapy is conducted under the supervision of a specialist.

General protocols exist for managing dose timing. If a morning or evening dose is missed by more than two hours after the scheduled meal, the standard procedure involves waiting until the next scheduled dose or skipping the dose entirely, respectively. For older adults, a smaller and less frequent dose may be sufficient to achieve the desired clinical response.

Evidence for Use in Symptomatic Male Hypogonadism

Research has focused on men with confirmed low hormone levels and noticeable symptoms. Key evidence consists of short-term to intermediate-term randomized controlled trials (RCTs) that evaluated the medicine in comparison to a placebo over defined time intervals. These studies were designed to monitor the measurement of serum testosterone levels and whether they remained within the normal range, a primary regulatory objective. Studies monitored various patient experiences using scales and questionnaires, exploring symptoms related to systemic or functional imbalance, such as changes in libido and fatigue. Research describes patterns measured during the study period across these outcomes.

---

Outcomes Measured in Clinical Trials

The research examined two main groups of outcomes. The first involved hormonal biomarkers; studies monitored the measurement of serum testosterone levels in relation to the reference range. The second group related to patient-reported experiences. Research examined outcomes related to sexual function, energy levels, and changes in mood. Some studies also evaluated whether the therapy was associated with changes in physical parameters, such as muscle mass and body fat distribution, and metabolic markers like blood sugar control.

---

Long-Term Data and Scientific Uncertainty

Randomized controlled trials frequently feature limited follow-up durations, often lasting only 12 weeks to 12 months. Therefore, long-term effects are not fully established based on the highest level of evidence. Longitudinal observational studies contribute to observed patterns regarding the sustained maintenance of hormone levels and the progression of certain physical markers over time. However, certainty remains low for many extended outcomes. Specific evidence is limited for healthy older men, and data are still developing and research continues regarding any potential association with cardiovascular outcomes.

Key Studies & References

1. ATC Code G03BA03 - Testosterone undecanoate
2. MedlinePlus Drug Information: Testosterone capsule (oral) for low testosterone (a616035)
3. MedlinePlus Drug Information: Testosterone general use/symptom management (a619028)

Common questions about Restandol (Testosterone) (FAQ)

Q: What is Restandol (Testosterone) and what is it used for?

Restandol Testocaps are soft capsules that contain testosterone undecanoate, which the body converts into testosterone, a naturally occurring male hormone (androgen).

Uses:

• Testosterone replacement therapy in adult men for conditions caused by a lack of natural testosterone, known as male hypogonadism. This condition should be confirmed by two separate blood tests and clinical symptoms, which can include:
  • Impotence
  • Infertility
  • Low sex drive (libido)
  • Tiredness and depressive moods
  • Bone loss (osteoporosis) caused by low hormone levels

Q: What are the possible side effects of Restandol (Testosterone)?

Like all medicines, Restandol can cause side effects, though not everybody gets them. Possible side effects reported during testosterone therapy include:

• General Effects: Rash, nausea (feeling sick), yellowing of the skin or eyes (jaundice), increased or decreased sex drive, depression, nervousness, mood changes, muscle pain, high blood pressure, and changes in the way the body processes fats.
• In Men: Enlargement of the breasts (gynecomastia), growth of the prostate gland, worsening of an early-stage prostate cancer, difficulty passing urine, prolonged painful erection (priapism), and decreased amounts of ejaculation fluid and sperm.
• In Women: Increase in facial or body hair, acne, absence or lighter periods, and voice changes, which may not return to normal.
• In Children: Early sexual development and delayed bone growth.
• Other: Allergic reactions, including to the colorant Sunset Yellow (E110), and allergic-type reactions in those who may be allergic to aspirin. Stomach pain or discomfort has also been reported.

Q: Can Restandol (Testosterone) be taken with other medicines?

Yes, but you must tell your doctor or pharmacist about all other medicines you are taking or plan to take, as they may interact with Restandol. This is particularly important for:

• Anticoagulant medicines (blood thinners)
• Anti-diabetic medicines
• The hormone ACTH or corticosteroids (used to treat conditions like rheumatism, arthritis, allergic conditions, and asthma), as Restandol may increase the risk of water retention, especially in those with heart or liver disease.

Q: How should Restandol (Testosterone) be taken?

Restandol capsules must always be taken with a normal meal to ensure proper absorption of the active ingredient, testosterone undecanoate. The capsules should be swallowed whole with a little fluid, without chewing. The daily dose is often divided, with half taken in the morning and the other half in the evening.

How to Store and Dispose of Restandol (Testosterone)?

Official regulatory guidelines strictly define the necessary storage conditions to maintain the medicine's stability and safety.

Restandol must be stored at controlled room temperature, generally defined as 20 C to 25 C (68 F to 77 F), or kept below 30 C. It is mandatory to keep the medicine out of the sight and reach of children to prevent accidental ingestion. The medication must be protected from environmental extremes, meaning it should not be refrigerated or frozen, and it must be stored in the original container to protect it from moisture.

For disposal, the product should not be discarded via wastewater or household waste. Expired or unused medication should be disposed of in a manner that protects the environment, such as through an official medication take-back program or as instructed by a healthcare professional or pharmacist.